Leadership

The team.

Immunology, computational biology, physics, regulatory science and clinical practice, under one roof.

Leadership & directors

Dr. Hector Zenil, FRSM

Dr. Hector Zenil, FRSM

Founder, CEO & CVO

Ph.D. in Computer Science (Lille) & Ph.D. in Epistemology (Paris, Sorbonne, ENS). Fellow of the Royal Society of Medicine. Associate Professor in Healthcare Engineering at King's College London. Lab leader and senior researcher affiliated to five of the world's top universities in AI and Computer Science (Cambridge, Oxford, MIT, CMU) and in Medicine (Karolinska). He helped develop the factual answering AI engine behind Siri and Alexa, reporting to Wolfram Research's CEO, Stephen Wolfram. A NASA Payload team member at MIT for the Mars Gravity Biosatellite. He has been a trustee, board and advisor member of multiple organisations.

Read full profile
Allan Bezanson

Allan Bezanson

Director

Director of several public and private companies. He has a background in private equity & financial services with a demonstrated history of successfully building businesses as a leader and investor. Notable past successes Nowsco, Altus, Bluewave Energy, FCF Capital, Polaris, and Voxtur.

John Cullen

John Cullen

Board Chair

Current CEO of JHI Associates. 30+ years experience in public company financing, corporate/capital structuring and management. 20+ years corporate experience in the energy sector. Founded a number of public international resource companies following 15+ years in the Canadian investment industry.

Prof. Jesper N. Tegnér

Prof. Jesper N. Tegnér

Director

Ph.D. in neurosciences (Karolinska). Professor of Bioscience and Computer Science (KAUST) specialised in AI applied to systems medicine and single-cell genomics. Founder of award-winning startups in Sweden. Chaired full professorship in Computational Biology, the first of its kind in Sweden, and Strategic chaired full professor in Computational Medicine, Karolinska Institutet & Division of Clinical Epidemiology, Karolinska Hospital.

Dr. Roger Ferguson, Jr.

Dr. Roger Ferguson, Jr.

Director

J.D. and a Ph.D. in economics (Harvard). Past President and CEO of TIAA, a Fortune 100 financial services organisation. Former head of financial services for Swiss Re and Chairman of Swiss Re America Holding Corporation. Former Vice Chairman of the Board of Governors of the U.S. Federal Reserve. Serves on the boards of Alphabet, Inc., the Institute for Advanced Study, and Memorial Sloan Kettering Cancer Center, among others.

Dr. Pradip Banerjee

Dr. Pradip Banerjee

Director

Visionary C-Suite leader, seasoned board director, and serial venture creator with 30+ years of experience building, scaling, and exiting companies across life sciences, SaaS, and healthcare technology. Served as Chairman & CEO of Xybion Digital Inc., transforming a $4M niche SaaS provider into a global market leader serving 350+ enterprise clients across 35 countries with a landmark 40X+ MOIC exit. As Founding Managing Partner at Accenture, he launched and scaled the firm's Life Sciences R&D consulting business into a $1B global unit.

Prof. Kourosh Saeb-Parsy

Prof. Kourosh Saeb-Parsy

Chief Medical Officer

MD & PhD in neurosciences. Professor of Transplantation, group leader, Department of Surgery, Cambridge University. NHS Consultant Transplant Surgeon. Specialises in immunogenicity of cancer and regenerative cellular therapies. Multiple experiences leading start-ups to success.

Advisors

A global network of clinicians, scientists and operators guiding our work.

Pamela Winsor

Pamela Winsor

Advisor

eMBA (2000) at St. Mary's University, Halifax and the ICD.D (2015) with Rotman School of Business, Toronto. 20+ years as a Senior Healthcare Executive, including 14 years at Medtronic as CMO, the world's largest medical device manufacturer. Member of the Canadian College of Health Leaders, and a visionary leader in patient-centric healthcare. Rotman, Judy Project Alumni and an executive coach.

Abel Archundia

Abel Archundia

Advisor

Former Head of Digital Transformation and IT for Bayer Pharmaceuticals. Member of the group's Digital Transformation Board as well as the Bayer Group IT board. Former Global Head, Novartis TechOps/QA IT and Sandoz Division IT of Novartis. Former supply chain manager for Dell and General Manager (US$500M business) on the vendor side. CIO with broad experience, especially in large-scale transformation efforts.

Prof. Petter Brodin

Prof. Petter Brodin

Advisor

Garfield Weston Chair & Professor of Paediatric Immunology (Imperial College) & Professor of Paediatric Immunology (Karolinska Institutet). Develops novel methods to describe human immune system variation.

Dr. Sam Toney

Dr. Sam Toney

Advisor

Chief Medical Officer of Carespan with over thirty years of clinical management experience in health plan populations including Medicare, Medicaid, Tricare and commercial lines of business. Frequent speaker at Medicaid Managed Care Congress and Medicaid Health Plans of America Conference, and has presented on national webinars for Health Plan Alliance.

Dr. Rolf Porsche

Dr. Rolf Porsche

Advisor

Physician, healthcare strategist, and innovation leader. He has served in senior roles including at IBM Global Business Services as Partner and Head of Healthcare Consulting, driving strategic initiatives at the interface of medicine and technology. He has supported, managed and driven projects achieving an overall revenue of over €100 billion.

Prof. Patrick Tighe

Prof. Patrick Tighe

Advisor

Professor of Molecular Immunology (Nottingham) specialised in molecular cloning, T cell receptor analysis, fluorescent detection technologies & immunoassay tech.

Dr. Jason Berman

Dr. Jason Berman

Advisor

Full Professor of Paediatrics and Cellular & Molecular Medicine at the University of Ottawa. Clinician, researcher and thought leader. Serves as CEO & Scientific Director of the Children's Hospital of Eastern Ontario (CHEO).

Dr. Corey Cutler

Dr. Corey Cutler

Advisor

MD, MPH, FRCP(C). Medical Director of the Stem Cell Transplantation Program at the Dana-Farber Cancer Institute & Associate Professor of Medicine at Harvard Medical School. Author of 300+ publications and 40 reviews and book chapters.

Dr. Narsis A. Kiani

Dr. Narsis A. Kiani

Advisor

Lab leader and senior researcher at the Department of Oncology-Pathology and the Algorithmic Dynamics Lab, Karolinska Institute. BEng in medical engineering, BSc in pure mathematics, MSc and PhD in applied mathematics. Former VINNMER (Vinnova-Marie Curie) Fellow.

Tony Cambridge

Tony Cambridge

Advisor

Managing Director of Thornhill Healthcare Events & Consultancy, and Lead Biomedical Scientist in the Pathology Management team of a major trauma centre and acute care NHS hospital in England. Over 25 years' experience in pathology & diagnostics.

Prof. Weizi Li

Prof. Weizi Li

Advisor

Associate Professor of Informatics & Digital Health, Deputy Director in the Informatics Research Centre, Henley Business School, University of Reading. Principal Investigator of the EPSRC project on the 'Future blood testing for inclusive monitoring and personalised analytics Network+'.

Martin Korbmacher

Martin Korbmacher

Advisor

Founder and Managing Partner of Event Horizon Capital & Advisory GmbH, a Corporate Finance Boutique and investment vehicle. Chairman of the supervisory board of the publicly listed flatexDEGIRO AG, and Chairman of the supervisory board of the publicly listed SGT Private Equity GmbH & Co. KGaA.

Rembert de Villa

Rembert de Villa

Advisor

Has held leadership roles at EXL Healthcare, Mastercard, and Capgemini. Serves on several boards, including Carespan and the Joseph Brant Hospital Foundation.

Dr. Syed Ahsan Raza

Dr. Syed Ahsan Raza

Advisor

Senior Clinical Scientist at the Trauma and Transfusion Medicine Research Center, University of Pittsburgh, with expertise spanning epidemiology (Ph.D.), infectious disease, big data analytics, clinical adaptive trials, Bayesian analysis, and AI. Former cancer researcher at Baylor College of Medicine, from where he received his MD followed by postgraduate studies at Harvard. Over 50 peer-reviewed publications.

Dr. Andrew King

Dr. Andrew King

Advisor

Consultant haematologist and clinical lead for haemato-oncology at Cambridge University Hospitals NHS Foundation Trust. Specialised in acute leukaemia, myeloma and bone marrow transplantation/cellular therapy. Principal or sub-investigator on several late-phase clinical trials. DPhil in molecular biology at the Weatherall Institute, University of Oxford. Co-author of Lecture Notes in Haematology.

Dr. Hamid Sadri

Dr. Hamid Sadri

Advisor

Director of Policy, Health Economics & Outcomes Research at Medtronic ULC. Holds a doctorate in clinical pharmacy and two graduate degrees in health economics and healthcare management from the University of Toronto. Registered pharmacist in Ontario and a member of the Canadian College of Health Leaders.

Bring regular immune monitoring to your patients.

Book a 20-minute briefing with our clinical team to see Algocyte in action.